High Net Worth Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-70
Closed -$28.6K – 371
2022
Q4
$28.6K Hold
70
– – 0.01% 392
2022
Q3
$23K Buy
70
+5
+8% +$1.84K 0.01% 432
2022
Q2
$23K Buy
65
+7
+12% +$2.85K 0.01% 429
2022
Q1
$32K Hold
58
– – 0.01% 395
2021
Q4
$38K Buy
+58
New +$36.4K 0.01% 377

Other funds holding IDXX

High Net Worth Advisory Group's IDXX Position: Q1 2023 in Review

High Net Worth Advisory Group sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 70 shares — an estimated $28.6K sold.

High Net Worth Advisory Group first reported a position in IDXX in Q4 2021 and held it in 5 quarters. The position peaked at $38K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • High Net Worth Advisory Group reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • High Net Worth Advisory Group sold 70 Idexx Laboratories shares in Q1 2023, an estimated $28.6K.
  • High Net Worth Advisory Group first reported a position in Idexx Laboratories in Q4 2021 and held it in 5 quarters.
  • High Net Worth Advisory Group's Idexx Laboratories position peaked at $38K in Q4 2021.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on High Net Worth Advisory Group's 13F filing for Q1 2023, filed 20 Apr 2023.